Covid vaccine 5-11 years, Pfizer submits an ok request to Fda

by

Vaccine covid 5-11 years, Pfizer has submitted the request to the FDA for the ok for use in the U.S. This is the update communicated by Pfizer, via Twitter, after the company in recent days together with BioNTech had started l ‘process by presenting to the US agency the data from the phase 2/3 study on the anti-Covid vaccine in children aged between 5 and 11 years. “We have officially submitted our request to the FDA for the authorization for the emergency use (Eua)” in the US “of our anti-Covid vaccine in children from 5 to less than 12 years”, reads the post. ]]>